Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 8.840 -0.060 (-0.67%) Official Closing Price Updated: 8:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cybin Inc < Previous 1 2 3 4 5 6 7 8 9 ... 38 39 Next > PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in Upcoming Water Tower Research Fireside Chat October 03, 2024 Via Investor Brand Network Exposures Product Safety Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024 October 03, 2024 From Cybin Inc. Via Business Wire PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Strengthens Its Clinical Development Team October 01, 2024 Via Investor Brand Network Cybin Expands Clinical Team to Support CYB003 Phase 3 Program October 01, 2024 From Cybin Inc. Via Business Wire CYBN Stock Earnings: Cybin Beats EPS for Q1 2024 August 09, 2024 CYBN stock results show that Cybin beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace CYBN Stock Earnings: Cybin Beats EPS for Q4 2023 June 26, 2024 CYBN stock results show that Cybin beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Chief Medical Officer to Participate in a Panel Discussion at Upcoming Summit September 24, 2024 Via Investor Brand Network Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit September 24, 2024 From Cybin Inc. Via Business Wire PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Reports on Status of Key Clinical Milestones September 20, 2024 Via Investor Brand Network Cybin Provides Corporate Update on Upcoming Clinical Milestones September 19, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Completes 38-for-1 Share Consolidation September 19, 2024 Via Investor Brand Network Cybin Announces Completion of Previously Announced Share Consolidation September 19, 2024 From Cybin Inc. Via Business Wire Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More September 06, 2024 Maryland transitioned to an adult-use cannabis market a little over a year ago. Led by the state's Cannabis Administration Director, Will Tilburg, the transition resulted in the state's legal cannabis... Via Benzinga Topics Cannabis Exposures Cannabis InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate at the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 Via Investor Brand Network Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Reports on Annual and Special Meeting of Shareholders, Share Consolidation August 28, 2024 Via Investor Brand Network Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation August 27, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Holds Initial Breakthrough Therapy Meeting with FDA, Plans for CYB003 Phase 3 Trial August 13, 2024 Via Investor Brand Network Exposures Product Safety Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder August 13, 2024 From Cybin Inc. Via Business Wire BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases Q1 2025 Financial Results, Business Highlights August 08, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights August 08, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference August 07, 2024 Via Investor Brand Network Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference August 07, 2024 From Cybin Inc. Via Business Wire EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves July 31, 2024 Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy. Via Benzinga 3 Biotech Stocks That Could Make Your Summer Unforgettable July 30, 2024 If you want to do well with biotech stocks, trade the anticipation of news. Here are three stocks to consider. Via InvestorPlace Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN) July 10, 2024 Via AB Newswire Exposures Product Safety PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees “Swell” of Insider Investments, Upgrade in Ranking after Positive Year-End Report July 08, 2024 Via Investor Brand Network Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns July 03, 2024 Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks. Via InvestorPlace 3 Psychedelic Stocks to Buy on the Dip: Summer 2024 July 02, 2024 These are three of the best psychedelic stocks to buy on the dip for potentially lucrative future growth and returns. Via InvestorPlace Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development June 26, 2024 Explore Cybin Inc.'s FY 2024 results: $78M loss and strides in psychedelic therapy for mental health. Read now! Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 38 39 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.